Atom Investors »

Fate Therapeutics shares owned by Atom Investors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Atom Investors from 13F filings

Historical chart of Atom Investors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Atom Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Atom Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $139k 110k 1.26

More positions owned by Atom Investors

Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 2000 Val Etf (IWN)
Spdr Series Trust S&p Retail Etf (XRT)
Select Sector Spdr Tr Financial (XLF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust S&p Homebuild (XHB)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Spdr Series Trust S&p Biotech (XBI)
Carlisle Companies (CSL)
Select Sector Spdr Tr Indl (XLI)
Ollies Bargain Outlt Hldgs I (OLLI)
Entergy Corporation (ETR)
Ishares Tr Msci Usa Min Vol (USMV)
Viper Energy Cl A (VNOM)

View all positions for Atom Investors

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Vestal Point Capital
Morgan Stanley
State Street Corporation
Dimensional Fund Advisors
Tang Capital Management
Goldman Sachs Group
Renaissance Technologies
AQR Capital Management

View all funds holding Fate Therapeutics